APPOS Virtual - Boston


March 5th - March 6th, 2021

Agenda

Please note: times are subject to change. Please check the syllabus for the most current version of the agenda upon arriving at the summit.

All Times Listed are for the Eastern Time Zone

Friday, March 5, 2021

8:00am

Virtual Webcast Technical Overview

8:10am

Welcome, Introductions, & CE Housekeeping

8:15am

(01) Precision Medicine in Oncology: Integrating Cancer Genomics into Patient Care
» Jochen K. Lennerz, MD - Massachusetts General Hospital

9:15pm

Exhibitor Announcements | Meet-the-Clinician (Non CME)

9:35 am

(02) HR+/HER2- Metastatic Breast Cancer: An Update for APPs
» Melissa Sullivan, MSN, APRN-CNP, FNP-C - The Stefanie Spielman Comprehensive Breast Center

10:35 am

Break & Virtual Exhibit Hall | Meet-the-Clinician (Non CME)

10:55 am  

(03) Geriatric Oncology Care: Addressing the Unique Health Needs of Aging Patients with Cancer
» Tammy T. Hshieh, MD - Brigham and Women's Hospital; Dana Farber Cancer Institute

11:55 am

Break & Virtual Exhibit Hall (Non CME)

12:10 pm

Non-CE/CME Symposium Sponsored by Incyte (Jakafi®)
Intervening with Jakafi® (ruxolitinib) to Achieve Durable Count Control: Focus on Adults With Polycythemia Vera Who Have an Inadequate Response to Hydroxyurea
» Charina Toste, NP

12:45 pm

(04) Clinically Significant Drug Interactions Associated with Complementary/Alternative Medicine
» Hillary Prescott, PharmD, BCOP - Dana-Farber Cancer Institute

1:45 pm

Clinical Conversations (Non-CME) - Transitioning Drugs for Lung Cancer Patients

 2:05 pm

(05) Molecular Testing and Team-Based Care: Optimizing Community Care of Patients with mNSCLC
» Beth Sandy, MSN, CRNP - Abramson Cancer Center, University of Pennsylvania

Saturday, March 6, 2021

8:00am

Virtual Webcast Technical Overview

8:10am

Welcome, Introductions, & CE Housekeeping

8:15am

(06) Managing Patients with Relapsed/Refractory Multiple Myeloma: An Update on Emerging Strategies
» Houry Leblebjian, PharmD, BCOP - Dana Farber Cancer Institute

9:15pm

Exhibitor Announcements | Meet-the-Clinician (Non CME)

9:35 am

(07) The Evolution of Drug Therapy in Oncology: Recent Advances in Cancer Drug Therapy
» Rowena (Moe) Schwartz, PharmD, BCOP, FHOPA - University of Cincinnati Barrett Cancer Center

10:35 am

Break & Virtual Exhibit Hall | Meet-the-Clinician (Non CME)

10:55 am 

(08) An Update on Myelodysplastic Syndrome (MDS) for Advanced Practice Providers
» Anita Kumar, MD, MSCE - Tufts Medical Center

11:55 am

Break & Virtual Exhibit Hall (Non CME)

12:10 pm

Non-CME/CE Symposium Presentation Sponsored by Rigel
Case Study - Stand Strong Against Platelet Destruction with TAVALISSE: A Patient’s ITP Treatment Journey
» Christopher Nelson, ACNP-BC

12:45 pm

(09) Role of Technology in Care Delivery with a Focus on Telehealth
» Kaitlen Reyes, FNP, DNP - Dana Farber Cancer Institute

1:45 pm

Clinical Conversations (Non-CME) - Toxicity with TKI's

2:05 pm

(10) Lung Cancer Management Strategies in Patients with COVID: Real Life Experiences from a Thoracic Cancer Practice and an APP-led Ambulatory Oncology Clinic
» Kelly Goodwin, NP - Massachusetts General Hospital
» AJ Piper-Vallillo, MD - Massachusetts General Hospital
» Meghan J. Mooradian, MD - MGH Cancer Center

3:05 pm

Closing Comments

$60.00